Moa Life Plus

Moa Life Plus EPS

The Earnings per Share (EPS) of Moa Life Plus (142760.KQ) as of Nov 3, 2026 is -817.73 KRW. In the previous year, Earnings per Share (EPS) was -438.21 KRW — a change of 86.61% (lower).

EPS

-817.73KRW

YoY

86.61%

Last updated:

Earnings per Share (EPS) of Moa Life Plus is 2025 -817.73 KRW. Earnings per Share (EPS) of Moa Life Plus was 2024 -438.21 KRW. It decreases by 86.61% lower compared to the previous year.

The Moa Life Plus EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2018
-1,079.45 KRW
Jan 1, 2019
-1,757.23 KRW
Jan 1, 2020
-1,324.42 KRW
Jan 1, 2021
-1,238.55 KRW
Jan 1, 2022
-1,449.68 KRW
Jan 1, 2023
501.80 KRW
Jan 1, 2024
-438.21 KRW
Jan 1, 2025
-817.73 KRW
The Moa Life Plus EPS history
YEAREPSYoY
-817.73KRW+86.61%
-438.21KRW-187.33%
501.80KRW-134.61%
-1,449.68KRW+17.05%
-1,238.55KRW-6.48%
-1,324.42KRW-24.63%
-1,757.23KRW+62.79%
-1,079.45KRW+159.20%
-416.46KRW+12.74%
-369.40KRW-68.37%
-1,167.85KRW+5.06%
-1,111.57KRW+210.59%
-357.89KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Moa Life Plus Stock analysis

What does Moa Life Plus do? BL Corp. develops biopharmaceutical products and manufactures health functional foods and functional cosmetics. The company distributes Glu 100 Tablets, CellribonQ, and GentaQ to general hospitals and pharmacies. It generates revenue through the sale of these pharmaceuticals and health-related products to healthcare providers and retail outlets. The firm's product portfolio includes Glu 100 Tablets, CellribonQ, and GentaQ, which are distributed to general hospitals and pharmacies. These products are sold as part of the company's pharmaceutical and medical supplies distribution business. Revenue is derived from the sale of these branded medicines and health functional products. BL Corp. focuses on the distribution of specific branded pharmaceuticals and health functional products. The company's primary customers are general hospitals and pharmacies, which purchase Glu 100 Tablets, CellribonQ, and GentaQ for resale or direct use in healthcare settings. Moa Life Plus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Moa Life Plus stock

Earnings per Share (EPS) of Moa Life Plus is -817.73 KRW in 2025.

Earnings per Share (EPS) of Moa Life Plus changed from -438.21 KRW to -817.73 KRW, representing a 86.61% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Moa Life Plus since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Moa Life Plus

All Key Metrics — Moa Life Plus